Whole genome and exome sequencing of pNENs to investigate PRRT response

A new study looked at the DNA of pancreatic neuroendocrine tumours (pNETs) to see whether genetic changes could explain why some patients respond better than peptide receptor radionuclide therapy (PRRT) than others.

Click here to learn more